Rahul G Muthalaly
Overview
Explore the profile of Rahul G Muthalaly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muthalaly R, Abrahams T, Lin A, Patel K, Tan S, Dey D, et al.
Int J Cardiovasc Imaging
. 2024 Oct;
40(11):2237-2245.
PMID: 39400790
Myocardial fibrosis is a common endpoint of many cardiac diseases and increasingly recognized as a predictor of heart failure, arrhythmia, and death. Recent studies have utilised cardiac computed tomography (CT)...
2.
Muthalaly R, Tan S, Nelson A, Abrahams T, Han D, Tamarappoo B, et al.
J Cardiovasc Comput Tomogr
. 2024 Jun;
18(5):457-464.
PMID: 38879421
Background: Cardiac computed tomography quantification of extracellular volume fraction (CT-ECV) is an emerging biomarker of myocardial fibrosis which has demonstrated high reproducibility, diagnostic and prognostic utility. However, there has been...
3.
Tan S, Nelson A, Muthalaly R, Ramkumar S, Hamilton J, Nerlekar N, et al.
Eur J Prev Cardiol
. 2024 Jun;
PMID: 38870247
Cardiovascular disease is the leading cause of non-cancer related mortality and morbidity among people living with or cured from cancer. Immune checkpoint inhibitors (ICIs) are systemic anti-cancer therapies that have...
4.
Muthalaly R, Lin A, Nerlekar N
JACC Cardiovasc Imaging
. 2024 Apr;
17(4):463.
PMID: 38569795
No abstract available.
5.
Muthalaly R, Abrahams T, Nerlekar N, Nelson A, Tan S, Chan J, et al.
Eur Stroke J
. 2024 Feb;
9(3):540-554.
PMID: 38357886
Background: Ischaemic stroke and coronary artery disease share risk factors and stroke survivors experience a high rate of cardiac events. Recent work suggests a high burden of asymptomatic coronary artery...
6.
Hay M, Muthalaly R, Tan S, Nerlekar N
Eur Heart J Case Rep
. 2023 Sep;
7(9):ytad429.
PMID: 37772030
Background: During the COVID-19 pandemic, there has been global administration of novel mRNA vaccines that are effective in reducing the burden of COVID-19. In tandem with this administration, mRNA vaccine-associated...
7.
Chan J, Thakur U, Tan S, Muthalaly R, Thakkar H, Goel V, et al.
Eur Radiol
. 2023 Jun;
33(12):8445-8453.
PMID: 37369831
Objectives: Epicardial adipose tissue (EAT) is a proposed marker of cardiovascular risk; however, clinical application may be limited by variability in post-processing software platforms. We assessed inter-vendor agreement of EAT...
8.
Muthalaly R, Nelson A, Baradi A, Mehta O, Wilson A, Nasis A
Int J Cardiol Cardiovasc Risk Prev
. 2023 May;
17:200184.
PMID: 37131952
Background: Cardiovascular disease burden is decreasing, but these reductions have not been distributed equally amongst socioeconomic groups. Objectives: The aim of this study was to define the relationships between different...
9.
Bywater L, Gist A, Muthalaly R, Loh J, Simpson I, White A, et al.
Med J Aust
. 2022 Aug;
217(5):232-234.
PMID: 35924379
No abstract available.
10.
Muthalaly R, John R
J Cardiovasc Electrophysiol
. 2022 Apr;
33(7):1403-1404.
PMID: 35437861
No abstract available.